First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers

by Abou-Alfa, G.K, Ansaldi, C., Awada, A., Bestion, E.N, Decaens, T., Dreyer, C., Halfon, P., Harding, J.J, Kotecki, N., Menut, A., Merle, P., Mezouar, S., Paradis, V., Rachid, M., Raymond, E., Roth, G.
Published 2022